Imaging shows ocular changes in chronic thromboembolic pulmonary hypertension

Article

The research team reported a few differences in patients that included a decreased mean vessel density at the deep vascular complex of the macula, a decreased mean subfoveal choroidal thickness, and an increase in the size of the foveal avascular zone.

Imaging shows ocular changes in chronic thromboembolic pulmonary hypertension

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have different retinal and choroidal microvascular findings compared with healthy controls, including a decreased mean vessel density at the deep vascular complex of the macula and a decreased mean subfoveal choroidal thickness, Dr Przemysław Krajewski, PhD, reported.

Dr Krawkewski, who is from the Ophthalmology Department, Infant Jesus Teaching Hospital, Medical University of Warsaw, Warsaw, Poland, and colleagues conducted an observational clinical cohort study1 to investigate the microvascular retinal and choroidal changes associated with CTEPH in patients compared with healthy control subjects.

The study included 36 patients (72 eyes) with CTEPH and 65 healthy control subjects (130 eyes). Optical coherence tomography (OCT) and OCT angiography images were obtained from each participant using the AngioVue Imaging System (Optovue, Inc., Freemont, California, USA).

Retinal findings

The research team reported a few differences in the patients with CTEPH that included a decreased mean vessel density at the deep vascular complex of the macula, a decreased mean subfoveal choroidal thickness, and an increase in the size of the foveal avascular zone.

In patients with CTEPH who had at least one systemic disease such as arterial hypertension, diabetes, chronic coronary syndrome, and/or hyperlipidemia, the range of the vascular complications increased. When a comorbidity was present there was an accompanying decrease in the mean vessel density in the superficial vascular complex of the macula, excluding the fovea, and a decrease in the mean vessel density in the radial peripapillary capillary plexus, the investigators reported.

The investigators theorized that measuring the foveal avascular zone and the vessel density of the deep vascular complex and subfoveal choroidal thickness may be useful and sensitive predictors of impaired retinal and choroidal circulation in patients with CTEPH without a systemic disease.

Reference
  1. Krawjewski P, Turczyńska M, Gołębiewska J, et al. Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension. Retina. 2022;42:2354-360; doi: 10.1097/IAE.0000000000003607

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
© 2025 MJH Life Sciences

All rights reserved.